India, Aug. 26 -- Gland Pharma Ltd has announced that it has received approval from the United States Food and Drug Administration (USFDA) for Vasopressin 5% Dextrose Injection USP, 40 Units/100 mL (0.4 Units/mL) RTU vial.
In addition, the company has also been granted tentative approval from the USFDA for Vasopressin 5% Dextrose Injection USP, 20 Units/100 mL (0.2 Units/mL) RTU vial.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....